RVMD — Revolution Medicines, Inc.

Ownership history in MPM BioImpact LLC  ·  18 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Revolution Medicines, Inc. (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.61% (2025 Q4)
Avg. % of fund
1.64%
First filed
2021 Q3
Last filed
2025 Q4
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 505,672 +189,950 +60.2% 4.61% $40.3M $79.65
2025 Q3 UNCHANGED 315,722 — 0% 2.41% $14.7M $46.70
2025 Q2 REDUCED 315,722 -1,361 -0.4% 2.01% $11.6M $36.79
2025 Q1 ADDED 317,083 +3,266 +1.0% 1.93% $11.2M $35.36
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RVMD price (monthly, adj. close)

Other funds also holding RVMD

As of 2025 Q4 — sorted by position size

AIHC Capital Management Ltd 67.21% Park Avenue Institutional Advisers LLC 3Y 7Y 40.5% Paradigm Biocapital Advisors LP 3Y 13.51% Casdin Capital, LLC 3Y 7Y 12.75% DAFNA Capital Management LLC 3Y 7Y 11.18% Alphabet Inc. 3Y 10.33% Logos Global Management LP 3Y 9.63% Checkpoint Capital L.P. 9.21% MIC Capital Management UK LLP 3Y 9.18% BVF INC/IL 3Y 7Y 9.0%
← Back to MPM BioImpact LLC Holdings